Prostatype Genomics announced the collaboration with Eurofins Megalab. The agreement means that Eurofins Megalab will manage all steps in the laboratory process required to analyze the Prostatype test on the Spanish and Portuguese markets. The collaboration is another step in Prostatype Genomics' work to further accelerate commercialization in Europe.

The agreement will enter into force immediately. Following previously communicated collaborations regarding priority markets, this means that Eurofins Megalab will manage the entire laboratory process on the Spanish and Portuguese markets, from initial contacts with healthcare providers to performing the gene analysis in their labs and reporting the results in accordance with Prostatype Genomics' quality-assured processes. Eurofins Megalab has a well-developed network of urologists and works in more than 50 private hospitals in Spain.

It provides opportunities for a fast sales development, since in addition to cooperation in laboratory services, it also includes cooperation between Prostatype Genomics' local Spanish organization and the commercial structures of Eurofins Megalab in Spain, which gives a great advantage to the commercialization of the Prostatype test.